![](/img/cover-not-exists.png)
AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma
Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Caserta, Claudia, Fabi, Alessandra, Clavarezza, Matteo, Maiello, Evaristo, Eoli, Marica, Lombardi, Giuseppe, Monteforte, MartLanguage:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/now035
Date:
March, 2016
File:
PDF, 332 KB
english, 2016